Estimated research and development costs of rotavirus vaccines
- 5 November 2009
- Vol. 27 (47) , 6627-6633
- https://doi.org/10.1016/j.vaccine.2009.07.077
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Rotavirus vaccine introduction in the Americas: progress and lessons learnedExpert Review of Vaccines, 2008
- The cost of biopharmaceutical R&D: is biotech different?Managerial and Decision Economics, 2007
- Are Development Times For Pharmaceuticals Increasing Or Decreasing?Health Affairs, 2006
- Setting the record straight in the reply by DiMasi, Hansen and GrabowskiJournal of Health Economics, 2005
- Setting the record straight on setting the record straight: Response to the Light and Warburton rejoinderJournal of Health Economics, 2005
- Extraordinary claims require extraordinary evidenceJournal of Health Economics, 2005
- Extraordinary claims require extraordinary evidenceJournal of Health Economics, 2005
- Do Drug Prices Reflect Development Time and Government Investment?Medical Care, 2005
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991